HCA Healthcare (HCA) Stock Rating Reaffirmed by Credit Suisse Group

HCA Healthcare (NYSE:HCA)‘s stock had its “outperform” rating reissued by equities researchers at Credit Suisse Group in a research note issued to investors on Tuesday. They currently have a $25.00 price objective on the stock. Credit Suisse Group’s target price indicates a potential downside of 71.94% from the company’s previous close.

A number of other research analysts have also issued reports on the stock. SunTrust Banks set a $105.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a research note on Thursday, December 21st. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 target price for the company. in a research note on Wednesday, December 20th. Zacks Investment Research upgraded shares of HCA Healthcare from a “strong sell” rating to a “hold” rating in a research report on Tuesday, December 19th. Citigroup upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating in a research report on Tuesday, December 12th. Finally, ValuEngine upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Thursday, November 30th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and nineteen have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $87.45.

HCA Healthcare (HCA) traded up $1.25 during trading on Tuesday, reaching $89.09. 1,908,800 shares of the company’s stock were exchanged, compared to its average volume of 2,306,275. The company has a debt-to-equity ratio of -6.46, a current ratio of 1.68 and a quick ratio of 1.41. The firm has a market cap of $31,542.54, a price-to-earnings ratio of 12.67, a price-to-earnings-growth ratio of 1.31 and a beta of 0.56. HCA Healthcare has a 52-week low of $71.18 and a 52-week high of $91.03.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.21. The firm had revenue of $10.70 billion during the quarter, compared to analyst estimates of $10.70 billion. HCA Healthcare had a net margin of 6.13% and a negative return on equity of 47.16%. HCA Healthcare’s revenue was up 4.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.45 EPS. research analysts anticipate that HCA Healthcare will post 6.56 earnings per share for the current year.

In related news, insider Michael S. Cuffe sold 2,400 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $86.63, for a total value of $207,912.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction that occurred on Wednesday, November 22nd. The stock was sold at an average price of $78.00, for a total transaction of $167,700.00. Following the completion of the sale, the insider now owns 12,476 shares in the company, valued at $973,128. The disclosure for this sale can be found here. Insiders sold a total of 22,700 shares of company stock worth $1,773,872 over the last quarter. Insiders own 2.90% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Mitsubishi UFJ Trust & Banking Corp raised its holdings in shares of HCA Healthcare by 0.9% during the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 628,845 shares of the company’s stock valued at $54,835,000 after acquiring an additional 5,870 shares during the period. Pacer Advisors Inc. raised its holdings in shares of HCA Healthcare by 8.4% during the second quarter. Pacer Advisors Inc. now owns 7,093 shares of the company’s stock valued at $619,000 after acquiring an additional 548 shares during the period. OMERS ADMINISTRATION Corp acquired a new stake in shares of HCA Healthcare during the second quarter valued at approximately $2,337,000. Micawber Capital LLC grew its position in HCA Healthcare by 6.7% during the second quarter. Micawber Capital LLC now owns 26,256 shares of the company’s stock valued at $2,290,000 after purchasing an additional 1,641 shares in the last quarter. Finally, Commerce Bank grew its position in HCA Healthcare by 1.4% during the second quarter. Commerce Bank now owns 13,320 shares of the company’s stock valued at $1,161,000 after purchasing an additional 182 shares in the last quarter. Institutional investors and hedge funds own 75.34% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “HCA Healthcare (HCA) Stock Rating Reaffirmed by Credit Suisse Group” was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.com-unik.info/2017/12/26/hca-healthcare-hca-stock-rating-reaffirmed-by-credit-suisse-group.html.

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

What are top analysts saying about HCA Healthcare? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HCA Healthcare and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit